login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
AARDVARK THERAPEUTICS INC (AARD) Stock News
USA
- NASDAQ:AARD -
US0029421007
-
Common Stock
10.7
USD
-0.15 (-1.38%)
Last: 10/24/2025, 8:07:33 PM
10.7
USD
0 (0%)
After Hours:
10/24/2025, 8:07:33 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AARD Latest News, Press Relases and Analysis
All
Press Releases
3 days ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics to Present Data on Pipeline Programs at Upcoming ObesityWeek
17 days ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics Announces FDA Alignment on Protocol Amendment Expanding Phase 3 HERO Trial Population for Prader-Willi Syndrome
24 days ago - By: Benzinga
- Mentions:
BLDR
COIN
POOL
WYFI
This Coinbase Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
2 months ago - By: The Motley Fool
Aardvark Therapeutics Reports Q2 Loss
a month ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics to Present at the Stifel 2025 Virtual Cardiometabolic Forum
a month ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics to Present at the Stifel 2025 Virtual Cardiometabolic Forum
2 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
2 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics to Present at Upcoming Investor Conferences in September
2 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics to Present at Upcoming Investor Conferences in September
2 months ago - By: Benzinga
- Mentions:
CDXS
VSTM
PULM
SNOA
...
12 Health Care Stocks Moving In Wednesday's After-Market Session
2 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics Reports Second Quarter 2025 Financial Results and Provides Pipeline and Business Updates
2 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics Reports Second Quarter 2025 Financial Results and Provides Pipeline and Business Updates
2 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics Announces ARD-201 Preclinical Obesity Data Showing Significant Weight Loss as a Monotherapy, Enhancement of GLP-1RA Therapy in Combination, and Effective Maintenance Following Discontinuation of GLP-1RA Therapy
2 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics Announces ARD-201 Preclinical Obesity Data Showing Significant Weight Loss as a Monotherapy, Enhancement of GLP-1RA Therapy in Combination, and Effective Maintenance Following Discontinuation of GLP-1RA Therapy
3 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
3 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
4 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics to Join Prader-Willi Syndrome Community at the 2025 United in Hope Conference
4 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics to Join Prader-Willi Syndrome Community at the 2025 United in Hope Conference
5 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal Functions
5 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal Functions
5 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
5 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
6 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics to Present at Upcoming Investor Conferences in May
6 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics to Present at Upcoming Investor Conferences in May
7 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights
7 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights
7 months ago - By: Yahoo Finance
- Mentions:
SLNO
CAR
RIVN
CNXC
Why Soleno Therapeutics Inc. (SLNO) Surged On Thursday?
7 months ago - By: Investor's Business Daily
- Mentions:
SLNO
Soleno Surges Into Breakout On Hard-Won Obesity-Tied Approval, Pulling Aardvark Higher
8 months ago - By: Aardvark Therapeutics, Inc.
Aardvark Therapeutics Announces Pricing of Initial Public Offering
Please enable JavaScript to continue using this application.